Spinal Muscular Atrophy Trial, Recruiting (NCT07321977)

Spinal Muscular Atrophy Trial, Recruiting NCT07321977 Sponsor: Institut de Myologie, France Condition: Spinal Muscular Atrophy

Printed from Voxsanity (voxsanity.com.au) — NCT07321977 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Spinal Muscular Atrophy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 65 years old
You are able to walk around (not confined to a wheelchair or bed)
You are willing to give your written agreement to take part in the study
You are covered by a social security or health insurance system
(For people with a neuromuscular disease only) You have a confirmed genetic neuromuscular disease from the study's approved list, with medical documents proving your diagnosis
(For people with a neuromuscular disease only) You are able to walk for at least 2 minutes without any help
(For people with a neuromuscular disease only) You are able to stand up from a chair with armrests at least 3 times within 30 seconds
(For people with a neuromuscular disease only) You are able to get to the movement analysis room by climbing a ramp, either on your own or with some help

Who may not be able to join:

People who are under a legal guardianship or court-appointed protection order
Women who are pregnant or breastfeeding
People who are not able to walk
People who have epilepsy
People with a skin condition that would prevent movement-tracking sensors from being placed on the skin
(For healthy volunteers only) People with unstable breathing or heart problems
(For healthy volunteers only) People with neurological, joint/muscle, or psychiatric conditions
(For people with a neuromuscular disease only) People who have had a serious injury or fall in the last 6 months
(For people with a neuromuscular disease only) People who have fallen more than twice in the past year AND at least once in the past three months
(For people with a neuromuscular disease only) People who use rigid knee braces or a walking frame
(For people with a neuromuscular disease only) People with an unstable heart muscle condition
(For people with a neuromuscular disease only) People who are still waiting for a diagnosis
People who are unable to follow the study's requirements for any reason
People whose personal health or social situation may interfere with the study, as decided by the research team (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 01 42 16 58 79

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07321977

Sponsor: Institut de Myologie, France

Phase: Not Applicable

Status: Recruiting

Condition: Spinal Muscular Atrophy

Trial contact: +33 01 42 16 58 79

More information: https://clinicaltrials.gov/study/NCT07321977

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 65 years old
You are able to walk around (not confined to a wheelchair or bed)
You are willing to give your written agreement to take part in the study
You are covered by a social security or health insurance system
(For people with a neuromuscular disease only) You have a confirmed genetic neuromuscular disease from the study's approved list, with medical documents proving your diagnosis
(For people with a neuromuscular disease only) You are able to walk for at least 2 minutes without any help
(For people with a neuromuscular disease only) You are able to stand up from a chair with armrests at least 3 times within 30 seconds
(For people with a neuromuscular disease only) You are able to get to the movement analysis room by climbing a ramp, either on your own or with some help

Who may not be able to join:

People who are under a legal guardianship or court-appointed protection order
Women who are pregnant or breastfeeding
People who are not able to walk
People who have epilepsy
People with a skin condition that would prevent movement-tracking sensors from being placed on the skin
(For healthy volunteers only) People with unstable breathing or heart problems
(For healthy volunteers only) People with neurological, joint/muscle, or psychiatric conditions
(For people with a neuromuscular disease only) People who have had a serious injury or fall in the last 6 months
(For people with a neuromuscular disease only) People who have fallen more than twice in the past year AND at least once in the past three months
(For people with a neuromuscular disease only) People who use rigid knee braces or a walking frame
(For people with a neuromuscular disease only) People with an unstable heart muscle condition
(For people with a neuromuscular disease only) People who are still waiting for a diagnosis
People who are unable to follow the study's requirements for any reason
People whose personal health or social situation may interfere with the study, as decided by the research team (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institut de Myologie, France

Registry

ClinicalTrials.gov

Start date

3 March 2026

Est. completion

6 July 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Vicon vs Myokinesis system correlation coefficient

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov